Medical Condition

breast carcinoma

Total Trials

11

Recruiting Now

11

Trial Phases

Phase 2, Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for breast carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — breast carcinoma Clinical Trials

How many clinical trials are currently recruiting for breast carcinoma?

ClinicalMetric currently tracks 11 actively recruiting clinical trials for breast carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for breast carcinoma?

breast carcinoma research spans Phase 1 (1 trial), Phase 2 (3 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a breast carcinoma clinical trial?

Eligibility criteria for breast carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

City of Hope Medical Center 4 trials

Mayo Clinic 2 trials

M.D. Anderson Cancer Center 1 trial

Ohio State University Comprehensive Cancer Center 1 trial

Istanbul Training and Research Hospital 1 trial

Recruiting Clinical Trials

NCT05557877 Phase 2

Recruiting

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

M.D. Anderson Cancer Center

View Trial →

NCT07341503

Recruiting

The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients

Ohio State University Comprehe...

View Trial →

NCT06954831 Phase 2

Recruiting

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

City of Hope Medical Center

View Trial →

NCT07207564

Recruiting

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer

Istanbul Training and Research...

View Trial →

NCT06130826 Phase 1

Recruiting

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

City of Hope Medical Center

View Trial →

NCT07741968

Recruiting

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

City of Hope Medical Center

View Trial →

NCT06144164 Phase 3

Recruiting

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Memorial Sloan Kettering Cance...

View Trial →

NCT06835426

Recruiting

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Algemeen Ziekenhuis Maria Midd...

View Trial →

NCT06731894 Phase 2

Recruiting

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

City of Hope Medical Center

View Trial →

Related Conditions

anatomic stage i breast cancer ajcc v8 (3) anatomic stage ii breast cancer ajcc v8 (3) anatomic stage iii breast cancer ajcc v8 (3) esophageal carcinoma (1) genitourinary system carcinoma (1) head and neck carcinoma (1) hematopoietic and lymphoid cell neoplasm (1) lung carcinoma (1) malignant central nervous system neoplasm (1) malignant digestive system neoplasm (1) malignant solid neoplasm (1) hormone receptor positive breast carcinoma (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology